Strategic appointments fuel global clinical and commercial development of AURN001, a transformational cell therapy with the potential to restore...

ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced...

CollPlant Biotechnologies, a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary...

The International Society for Stem Cell Research (ISSCR) is proud to announce the release of Best Practices for the Development of Pluripotent Stem...

Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that the US Food and Drug Administration (FDA) has granted...

Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that the US Food and Drug Administration (FDA) has granted...

HemostOD secures CHF 4.3 million seed extension to advance through pre-IND development and commercial scale production Lausanne, Switzerland — 1st...

Prefabricated systems manufactured under controlled conditions deliver the kind of reliability field fabrication cannot guarantee” — Thad Brown...

Competitive: Stanford University (US): The Clarke Lab at the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University School...

Competitive: Stanford University (US): The Clarke Lab at the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University School...